Hocoma Launches New Version of its Established Gait Training Device LokomatPro

ROCKLAND, Mass., June 28, 2011 /PRNewswire/ -- In strong collaboration with clinical research partners, Hocoma recently introduced a new and more compact version of the LokomatPro that offers greater system capabilities. Since the launch of Hocoma's first gait therapy device in 2001, the LokomatPro has established itself as an effective intervention for improving over-ground walking function in patients with neurological diseases and injuries resulting in gait impairment.

The new LokomatPro version was developed based on the needs and experience of patients and clinicians, as well as technological advances. The device provides extensive locomotion training to help trigger greater functional improvements in appropriate patients with spinal cord injury, stroke, brain injury and other neurological conditions. It features a new design and is equipped with the Augmented Feedback and a touch screen as a standard. In the future, upgrading options, including for example, additional degrees of freedom at the hip joint, sophisticated control strategy, higher gait speed, will extend the LokomatPro as a sophisticated gait training device supporting therapists and the patients in reaching their therapy goals. As in the preceding versions with the optional Pediatric Orthoses, the LokomatPro provides intensive locomotion therapy also for the treatment of children with cerebral palsy or other neurological disorders.

Over 300 Lokomat in over 50 countries worldwide

The Lokomat, a driven gait orthosis, is used for robotic gait training of neurological patients with movement disorders caused by stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, Parkinson's disease or other neurological diseases and injuries. The Lokomat has been available on the market since 2001 and has been a crucial improvement in the art and science of locomotion therapy. Currently, there are over 300 Lokomat systems successfully applied in over 50 countries worldwide. In the US about 90 systems are installed. The Kessler Foundation/Kessler Institute of Rehabilitation (West Orange, NJ) is the first center in the US using the new Lokomat generation to provide intensive gait training to patients for both clinical and research applications.

Hocoma

Hocoma was set up in 2000, as a spin-off of the Swiss University Hospital Balgrist. The company currently employs more than 130 people at its headquarters near Zurich, Switzerland and at its subsidiaries in the US and Singapore. Hocoma develops and produces therapy solutions for neurological patients with movement disorders caused by stroke, spinal cord injury, traumatic brain injury, multiple sclerosis or other neurological diseases and injuries as well as small children with cerebral palsy. The product range features devices for intensive locomotion therapy (Lokomat®, Andago®), functional therapy of the upper extremities (Armeo®) as well as early rehabilitation and patient mobilization (Erigo®). Hocoma's products are applied successfully in clinics and research institutes worldwide. This medical technology company has received many awards for start-up companies, and was honored with the "Red Herring 100 Global Award" in January 2010, as one of the hundred most innovative companies world-wide.

Media images: http://www.hocoma.com/en/about-us/media-center/media-images

SOURCE Hocoma